Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy von Anderson, Kristin G, Oda, Shannon K, Bates, Breanna M, Burnett, Madison G, Rodgers Suarez, Magdalia, Ruskin, Susan L, Greenberg, Philip D

Volltext

Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer von Anderson, Kristin G, Su, Yapeng, Burnett, Madison, Bates, Breanna, Suarez, Magdalia Rodgers, Voillet, Valentin, Gottardo, Raphael, Greenberg, Philip D

Volltext

Abstract 3608: Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer von Anderson, Kristin G., Su, Yapeng, Burnett, Madison G., Bates, Breanna M., Suarez, Magdalia L. Rodgers, Ruskin, Susan L., Vakil, Aesha, Voillet, Valentin, Gottardo, Raphael, Greenberg, Philip

Volltext